share_log

Marpai | 8-K: Current report

Marpai | 8-K:重大事件

SEC announcement ·  01/18 13:00
牛牛AI助理已提取核心訊息
On January 11, 2024, Marpai, Inc., a leading national Third-Party Administrator (TPA) in the healthcare sector, announced significant changes to its executive team. John Powers was appointed as the new President and Chief Operating Officer, effective January 2, 2024. Powers, an experienced healthcare benefits executive, previously served as CEO of Homestead Strategic Holdings and held leadership roles at Healthcomp Holdings and Advanced Medical Pricing Solutions. Alongside his appointment, Powers will receive a gross annual salary of $150,000, with eligibility for bonuses and equity grants. He was also granted a restricted stock unit for 150,000 shares of Marpai's Class A common stock, with a vesting schedule over two years and additional equity awards contingent on the company achieving certain EBITDA targets. Concurrently, CEO Damien Lamendola...Show More
On January 11, 2024, Marpai, Inc., a leading national Third-Party Administrator (TPA) in the healthcare sector, announced significant changes to its executive team. John Powers was appointed as the new President and Chief Operating Officer, effective January 2, 2024. Powers, an experienced healthcare benefits executive, previously served as CEO of Homestead Strategic Holdings and held leadership roles at Healthcomp Holdings and Advanced Medical Pricing Solutions. Alongside his appointment, Powers will receive a gross annual salary of $150,000, with eligibility for bonuses and equity grants. He was also granted a restricted stock unit for 150,000 shares of Marpai's Class A common stock, with a vesting schedule over two years and additional equity awards contingent on the company achieving certain EBITDA targets. Concurrently, CEO Damien Lamendola and CFO Steve Johnson entered into new employment agreements with similar compensation structures, including RSUs and performance-based equity awards. The company also announced the resignation of former COO Gonen Antebi, who entered into a separation agreement and will continue to provide services under a consulting agreement until November 30, 2024. Marpai's press release highlighted Powers' track record and the company's focus on client savings and high growth.
2024年1月11日,醫療保健領域領先的全國第三方管理機構(TPA)Marpai, Inc. 宣佈對其執行團隊進行重大調整。約翰·鮑爾斯被任命爲新任總裁兼首席運營官,自2024年1月2日起生效。鮑爾斯是一位經驗豐富的醫療福利高管,曾擔任霍姆斯特德戰略控股公司的首席執行官,並在Healthcomp Holdings和Advanced Medical Pricing Solutions擔任領導職務。除被任命外,鮑爾斯還將獲得15萬美元的年薪總額,並有資格獲得獎金和股權補助。他還獲得了Marpai15,000股A類普通股的限制性股票單位,歸屬計劃爲期兩年,額外的股權獎勵視公司實現某些息稅折舊攤銷前利...展開全部
2024年1月11日,醫療保健領域領先的全國第三方管理機構(TPA)Marpai, Inc. 宣佈對其執行團隊進行重大調整。約翰·鮑爾斯被任命爲新任總裁兼首席運營官,自2024年1月2日起生效。鮑爾斯是一位經驗豐富的醫療福利高管,曾擔任霍姆斯特德戰略控股公司的首席執行官,並在Healthcomp Holdings和Advanced Medical Pricing Solutions擔任領導職務。除被任命外,鮑爾斯還將獲得15萬美元的年薪總額,並有資格獲得獎金和股權補助。他還獲得了Marpai15,000股A類普通股的限制性股票單位,歸屬計劃爲期兩年,額外的股權獎勵視公司實現某些息稅折舊攤銷前利潤目標而定。同時,首席執行官達米安·拉門多拉和首席財務官史蒂夫·約翰遜簽訂了具有類似薪酬結構的新僱傭協議,包括限制性股票單位和基於績效的股票獎勵。該公司還宣佈前首席運營官戈南·安特比辭職,他簽訂了分離協議,並將繼續根據諮詢協議提供服務,直至2024年11月30日。Marpai的新聞稿強調了Powers的往績以及該公司對客戶儲蓄和高增長的關注。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。